| 查看: 577 | 回复: 1 | ||
| 当前只显示满足指定条件的回帖，点击这里查看本话题的所有回帖 | ||
18234074933新虫 (初入文坛)
|
[求助]
求翻译论文题目和摘要
|
|
|
RTB Lectin: a novel receptor- independent delivery system for lysosomal enzyme replacement therapies Enzyme replacement therapies have revolutionized patient treatment for multiple rare lysosomal storage diseases but show limited efectiveness for addressing pathologies in “hard-to-treat” organs and tissues including brain and bone. Here we investigate the plant lectin RTB as a novel carrier for human lysosomal enzymes. RTB enters mammalian cells by multiple mechanisms including both adsorptive-mediated and receptor-mediated endocytosis, and thus provides access to a broader array of organs and cells. Fusion proteins comprised of RTB and human α-L-iduronidase, the corrective enzyme for Mucopolysaccharidosis type I, were produced using a tobacco-based expression system. Fusion products retained both lectin selectivity and enzyme activity, were efciently endocytosed into human fbroblasts, and corrected the disease phenotype of mucopolysaccharidosis patient fbroblasts in vitro. RTB-mediated delivery was independent of high-mannose and mannose-6- phosphate receptors, which are exploited for delivery of currently approved lysosomal enzyme therapeutics. Thus, the RTB carrier may support distinct in vivo pharmacodynamics with potential to address hard-to-treat tissues. 发自小木虫Android客户端 |
回复此楼» 猜你喜欢
论文终于录用啦！满足毕业条件了
已经有21人回复
-
不自信的我
已经有5人回复
-
磺酰氟产物，毕不了业了！
已经有4人回复
-
投稿Elsevier的杂志（返修），总是在选择OA和subscription界面被踢皮球
已经有8人回复
2楼2015-11-02 19:59:17